首页 > 市场调查报告书 > 医疗设备

药物递输设备呼吸器

市场调查报告书

商品编码

1477313

数位剂量吸入器市场，按产品（定量吸入器、干粉吸入器等）、按类型、按适应症、按最终用户、按地理位置

Digital Dose Inhaler Market, By Product (Metered Dose Inhaler, Dry Powder Inhaler, Others), By Type, By Indication, By End User, By Geography

出版日期: 2024年04月11日 | 出版商:

Coherent Market Insights | 英文 176 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年全球数位剂量吸入器市值为183.3亿美元，预计2031年将达到643.3亿美元，2024年至2031年的年复合成长率（CAGR）为19.6%。

报告范围		报告详情
基准年：	2023年	2024 年市场规模：	183.3 亿美元
历史数据：	2019年至2023年	预测期：	2024年至2031年
预测 2024 年至 2031 年复合年增长率：	19.60%	2031 年价值预测：	643.3 亿美元

数字。数位剂量吸入器市场占有率 (%)，按地区 2024 年

数位剂量吸入器是一种便携式手持设备，用于输送药物以治疗哮喘和慢性阻塞性肺病等呼吸系统疾病。这些设备可侦测吸气并以空气雾化形式释放精确剂量的药物以供吸入。与传统的加压计量吸入器和干粉吸入器相比，数位剂量吸入器具有多种优点。它们配备了感测器，可以自动追踪药物使用情况，并透过蓝牙将资料传输到配套应用程式。这使得医生能够进行远端监控并确保用药依从性。连接的功能还允许吸入器向患者提供回馈和提醒。数位剂量吸入器旨在透过个人化治疗、严格的依从性监测以及与数位健康解决方案的整合来改善呼吸系统患者的治疗结果。

市场动态：

全球数位剂量吸入器市场的成长是由全球呼吸系统疾病盛行率不断上升、对药物依从性的日益关注、政府对呼吸系统疾病管理的有利倡议以及对互联数位健康解决方案的认识不断提高推动的。然而，与传统吸入器相比，数位吸入器的开发和製造成本较高，可能会阻碍市场成长。一些国家缺乏数位治疗设备的报销政策也阻碍了其采用。持续的技术进步、互联网和智慧型手机普及率的提高、数位吸入器的应用范围扩大到呼吸系统疾病以外的领域，为市场参与者提供了巨大的成长机会。

研究的主要特点：

该报告对全球数位剂量吸入器市场进行了深入分析，并提供了预测期（2024-2031）的市场规模（十亿美元）和年复合成长率（CAGR%），以2023年为基准年。
它阐明了不同细分市场的潜在收入机会，并解释了该市场有吸引力的投资主张矩阵。
这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
它根据以下参数描述了全球数位剂量吸入器市场的主要参与者——公司亮点、产品组合、主要亮点、财务表现和策略。
该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球数位剂量吸入器市场迎合了该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
利害关係人可以透过用于分析全球数位剂量吸入器市场的各种策略矩阵轻鬆做出决策。

介绍
北美洲
我们
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地区
欧洲
英国
德国
义大利
法国
西班牙
俄罗斯
欧洲其他地区
亚太地区
中国
印度
日本
东协
澳洲
韩国
亚太地区其他地区
中东
海湾合作委员会
以色列
中东其他地区
非洲
北非
中非
南非

第 10 章：竞争格局

公司简介
- 3M
- AstraZeneca
- GLENMARK PHARMACEUTICALS LTD.
- Novartis AG
- Sensirion AG
- Propeller Health
- OPKO Health, Inc.
- Teva Pharmaceutical Industries Ltd.
- BEXIMCO Pharmaceuticals
- GSK plc.
- Mundhipharma International
- Honeywell International Inc.
- Veranex
- Cognita Labs

第 11 章：分析师建议

命运之轮
分析师观点
连贯的机会图

第 12 章：参考文献与研究方法

参考
研究方法论

简介目录

Product Code: CMI6889

Global digital dose inhaler market is estimated to be valued at USD 18.33 Bn in 2024 and is expected to reach USD 64.33 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 19.6% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 18.33 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	19.60%	2031 Value Projection:	US$ 64.33 Bn

Figure. Digital Dose Inhaler Market Share (%), By Region 2024

Digital dose inhalers are portable handheld devices that are used for delivering medication to treat respiratory diseases like asthma and COPD. These devices detect inspiration and release an exact dose of medication in the air aerosolized form for inhalation. Digital dose inhalers offer several advantages over conventional pressurized metered dose inhalers and dry powder inhalers. These are equipped with sensors that can track medication use automatically and transmit the data via Bluetooth to a companion app. This enables remote monitoring by physicians and ensures medication adherence. The connected features also allow the inhalers to provide feedback and reminders to patients. Digital dose inhalers aim to improve treatment outcomes for respiratory patients through personalized therapies, strict adherence monitoring, and integration with digital health solutions.

Market Dynamics:

Global digital dose inhaler market growth is driven by growing prevalence of respiratory diseases globally, increasing focus on medication adherence, favorable government initiatives for respiratory disease management, and rising awareness about connected digital health solutions. However, the market growth can be hampered by high costs associated with developing and manufacturing digital inhalers as compared to conventional inhalers. Lack of reimbursement policies for digital therapeutic devices in some countries also hampers its adoption. Continual technological advancements, increasing internet and smartphone penetration, expanding applications of digital inhalers beyond respiratory diseases present significant growth opportunities for market players.

Key Features of the Study:

This report provides in-depth analysis of the global digital dose inhaler market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global digital dose inhaler market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study includes 3M, AstraZeneca, GLENMARK PHARMACEUTICALS LTD., Novartis AG, Sensirion AG, Propeller Health, OPKO Health, Inc., Teva Pharmaceutical Industries Ltd., BEXIMCO Pharmaceuticals, GSK plc., Mundhipharma International, Honeywell International Inc., Veranex and Cognita Labs
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global digital dose inhaler market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital dose inhaler market

Detailed Segmentation-

Product:
- Metered Dose Inhaler (MDI)
- Dry Powder Inhaler (DPI)
- Others
Type:
- Branded
- Generic
Indication:
- Asthma
- COPD
- Others
End User:
- Hospitals
- Homecare Settings
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- 3M
- AstraZeneca
- GLENMARK PHARMACEUTICALS LTD.
- Novartis AG
- Sensirion AG
- Propeller Health
- OPKO Health, Inc.
- Teva Pharmaceutical Industries Ltd.
- BEXIMCO Pharmaceuticals
- GSK plc.
- Mundhipharma International
- Honeywell International Inc.
- Veranex
- Cognita Labs

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Type
- Market Snapshot, By Indication
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Fundings and Investments
PEST Analysis
Porter's Analysis

4. Global Digital Dose Inhaler Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the market

5. Global Digital Dose Inhaler Market, By Product, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Metered Dose Inhaler (MDI)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Dry Powder Inhaler (DPI)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Digital Dose Inhaler Market, By Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Branded
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Generic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Digital Dose Inhaler Market, By Indication, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Asthma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
COPD
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Digital Dose Inhaler Market, By End User, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Homecare Settings
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Digital Dose Inhaler Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
North Africa
Central Africa
South Africa